Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons
- PMID: 38374224
- DOI: 10.1038/s41551-023-01150-x
Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons
Abstract
The blood-brain barrier (BBB) restricts the systemic delivery of messenger RNAs (mRNAs) into diseased neurons. Although leucocyte-derived extracellular vesicles (EVs) can cross the BBB at inflammatory sites, it is difficult to efficiently load long mRNAs into the EVs and to enhance their neuronal uptake. Here we show that the packaging of mRNA into leucocyte-derived EVs and the endocytosis of the EVs by neurons can be enhanced by engineering leucocytes to produce EVs that incorporate retrovirus-like mRNA-packaging capsids. We transfected immortalized and primary bone-marrow-derived leucocytes with DNA or RNA encoding the capsid-forming activity-regulated cytoskeleton-associated (Arc) protein as well as capsid-stabilizing Arc 5'-untranslated-region RNA elements. These engineered EVs inherit endothelial adhesion molecules from donor leukocytes, recruit endogenous enveloping proteins to their surface, cross the BBB, and enter the neurons in neuro-inflammatory sites. Produced from self-derived donor leukocytes, the EVs are immunologically inert, and enhanced the neuronal uptake of the packaged mRNA in a mouse model of low-grade chronic neuro-inflammation.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Appearance of claudin-5+ leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles.J Neuroinflammation. 2016 Nov 16;13(1):292. doi: 10.1186/s12974-016-0755-8. J Neuroinflammation. 2016. PMID: 27852330 Free PMC article.
-
Retrovirus-like gag protein Arc/Arg3.1 is involved in extracellular-vesicle-mediated mRNA transfer between glioma cells.Biochim Biophys Acta Gen Subj. 2024 Jan;1868(1):130522. doi: 10.1016/j.bbagen.2023.130522. Epub 2023 Nov 22. Biochim Biophys Acta Gen Subj. 2024. PMID: 37995879
-
Enrichment of the erythrocyte miR-451a in brain extracellular vesicles following impairment of the blood-brain barrier.Neurosci Lett. 2021 Apr 23;751:135829. doi: 10.1016/j.neulet.2021.135829. Epub 2021 Mar 13. Neurosci Lett. 2021. PMID: 33727125
-
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.Cells. 2020 Apr 1;9(4):851. doi: 10.3390/cells9040851. Cells. 2020. PMID: 32244730 Free PMC article. Review.
-
The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.Curr Pharm Des. 2017;23(40):6206-6214. doi: 10.2174/1381612823666170913164738. Curr Pharm Des. 2017. PMID: 28914201 Review.
Cited by
-
An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery.Pharmaceutics. 2024 Jun 22;16(7):849. doi: 10.3390/pharmaceutics16070849. Pharmaceutics. 2024. PMID: 39065547 Free PMC article. Review.
-
In Vitro and Animal Studies of Human Natural Killer Cell-Derived Exosomes for the Treatment of Otitis Media.Neurosci Bull. 2025 May 27. doi: 10.1007/s12264-025-01423-2. Online ahead of print. Neurosci Bull. 2025. PMID: 40423905
-
Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy.Int J Mol Sci. 2025 May 19;26(10):4835. doi: 10.3390/ijms26104835. Int J Mol Sci. 2025. PMID: 40429976 Free PMC article. Review.
-
Bioinspired cellular membrane-derived vesicles for mRNA delivery.Theranostics. 2024 May 19;14(8):3246-3266. doi: 10.7150/thno.93755. eCollection 2024. Theranostics. 2024. PMID: 38855184 Free PMC article. Review.
-
Using RNA therapeutics to promote healthy aging.Nat Aging. 2025 Jun;5(6):968-983. doi: 10.1038/s43587-025-00895-1. Epub 2025 Jun 11. Nat Aging. 2025. PMID: 40500390 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources